Active	Status	Sponsor type	Region	Phase	Filter
1 Active 7 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gvoke HypoPen (glucagon auto-injectable rescue pen) / Xeris Biopharma
2018-002661-19: A study to evaluate efficay and safety of G-Pen compared to GLUCAGEN® HYPOKIT®	Not yet recruiting	3	122	Europe	Xeris G-Pen, GlucaGen 1 mg, Solution for injection in pre-filled pen, Powder and solvent for solution for injection, GlucaGen Hypokit 1 mg	Xeris Pharmaceuticals, Inc, Xeris Pharmaceuticals, Inc	treatment of severe hypoglycemia, low sugar levels, Body processes [G] - Metabolic Phenomena [G03]

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gvoke HypoPen (glucagon auto-injectable rescue pen) / Xeris Biopharma
2018-002661-19: A study to evaluate efficay and safety of G-Pen compared to GLUCAGEN® HYPOKIT®	Not yet recruiting	3	122	Europe	Xeris G-Pen, GlucaGen 1 mg, Solution for injection in pre-filled pen, Powder and solvent for solution for injection, GlucaGen Hypokit 1 mg	Xeris Pharmaceuticals, Inc, Xeris Pharmaceuticals, Inc	treatment of severe hypoglycemia, low sugar levels, Body processes [G] - Metabolic Phenomena [G03]